Abstract
The aim of this study is to evaluate if mitomycin C (MMC), applied topically at the site of maxillary antrostomy in experimentally inflamed maxillary sinuses, may reduce postoperative ostial stenosis without any harmful effect. Twenty-four rabbits with experimentally induced maxillary sinusitis underwent maxillary antrostomy bilaterally. MMC at a concentration of 0.4 or 1 mg/ml was applied at the site of antrostomy on the right whilst the antrostomy site on the left served as the control. Half of each MMC concentration group of animals were killed after 3 weeks, and the remaining half after 6 weeks. For every rabbit, the areas of antrostomies were measured and mucosal specimens around the ostia were obtained for microscopic evaluation at the time of antrostomy and killing. Within each MMC concentration group, MMC-treated antrostomies were significantly wider than those of the controls (P < 0.05), even after 6 weeks. However, comparison of the areas of MMC-treated antrostomies between the two MMC concentration groups did not show any significant difference (P > 0.05). No systemic side effect or permanent mucosal damage was detected. These results suggest that postoperative topical MMC at a concentration of 0.4 mg/ml can be used to prolong the patency of maxillary antrostomy in an inflammed sinus.
Similar content being viewed by others
References
Ramadan HH (1999) Surgical causes of failure in endoscopic sinus surgery. Laryngoscope 109:27–29
Chambers DW, Davis WE, Cook PR, Nishioka GJ, Rudman DT (1997) Long-term outcome analysis of functional endoscopic sinus surgery: correlation of symptoms with endoscopic examination finding and potential prognostic variables. Laryngoscope 107:504–510
Palmer SS (1990) Mitomycin C as adjunct chemotherapy with trabeculectomy. Ophthalmology 98:317–321
Lee DA (1994) Antifibrosis agents and glaucoma surgery. Invest Ophthalmol Vis Sci 35:3789–3791
Ingrams DR, Volk MS, Biesman BS, Pankratov MM, Shapshay SM (1998) Sinus surgery: does mitomycin C reduce stenosis? Laryngoscope 108:883–886
Rahal A, Peloquin L, Ahmarani C (2001) Mitomycin C in sinus surgery: preliminary results in a rabbit model. J Otolaryngol 30:1–5
Jeong PS, Rhee CK, Jeon SY (1998) Platelet activating factor induced maxillary sinusitis in rabbits. Korean J Otolaryngol 41(9):1127–1132
Khaw PT, Occleston NL, Schultz G, Grierson I, Sherwood MB, Larkin G (1994) Activation and suppression of fibroblast function. Eye 8:188–195
Hu D, Sires BS, Tong DC, Royack GA, Oda D (2000) Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg 16:119–125
Kitazawa Y, Suemori-Matsushita H, Yamamoto T, Kawase K (1993) Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 100:674–677
Eliasher R, Eliachar I, Esclamado R, Gramlich T, Strome M (1999) Can topical mitomycin prevent laryngotracheal stenosis? Laryngoscope 109:1594–1600
Rahbar R, Shapshay SM, Healy GB (2001) Mitomycin: effects on laryngeal and tracheal stenosis, benefits and complication. Ann Otol Rhinol Laryngol 110:1–6
Estrem SA, Vanleeuwen RN (2000) Use of mitomycin C for maintaining myringotomy patency. Otolaryngol Head Neck Surg 122:8–10
Estrem SA, Batra PS (1999) Preventing myringotomy closure with topical mitomycin C in rats. Otolaryngol Head Neck Surg 120:794–798
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, SW., Koo, B.S., Park, Y.H. et al. Effect of topical mitomycin C for antrostomy in rabbit with sinusitis. Eur Arch Otorhinolaryngol 263, 917–923 (2006). https://doi.org/10.1007/s00405-006-0083-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-006-0083-1